CDC25B and ovarian carcinoma: In the case of ovarian cancer studies, found that the overexpression investigated using immunohistochemistry that the poor prognosis had a link to the overexpression of CDC25A and CDC25B in a sample of 106 patients (Broggini et al., 2000).